| Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon T Kato, T Date, M Miyamoto, A Furusaka, K Tokushige, M Mizokami, ... Gastroenterology 125 (6), 1808-1817, 2003 | 764 | 2003 |
| Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C S Yatsuji, E Hashimoto, M Tobari, M Taniai, K Tokushige, K Shiratori Journal of gastroenterology and hepatology 24 (2), 248-254, 2009 | 388 | 2009 |
| Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis E Hashimoto, S Yatsuji, M Tobari, M Taniai, N Torii, K Tokushige, ... Journal of gastroenterology 44, 89-95, 2009 | 358 | 2009 |
| Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. M Geissler, A Gesien, K Tokushige, JR Wands Journal of immunology (Baltimore, Md.: 1950) 158 (3), 1231-1237, 1997 | 356 | 1997 |
| Characteristics and diagnosis of NAFLD/NASH E Hashimoto, M Taniai, K Tokushige Journal of gastroenterology and hepatology 28, 64-70, 2013 | 342 | 2013 |
| Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis S Watanabe, E Hashimoto, K Ikejima, H Uto, M Ono, Y Sumida, M Seike, ... Journal of gastroenterology 50 (4), 364-377, 2015 | 341 | 2015 |
| Prevalence, gender, ethnic variations, and prognosis of NASH E Hashimoto, K Tokushige Journal of gastroenterology 46, 63-69, 2011 | 328 | 2011 |
| Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 K Tokushige, K Ikejima, M Ono, Y Eguchi, Y Kamada, Y Itoh, N Akuta, ... Journal of gastroenterology 56 (11), 951-963, 2021 | 230 | 2021 |
| Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis K Tokushige, M Takakura, N Tsuchiya-Matsushita, M Taniai, E Hashimoto, ... Journal of hepatology 46 (6), 1104-1110, 2007 | 198 | 2007 |
| The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease E Hashimoto, S Yatsuji, H Kaneda, Y Yoshioka, M Taniai, K Tokushige, ... Hepatology Research 33 (2), 72-76, 2005 | 163 | 2005 |
| Expression and immune response to hepatitis C virus core DNA–based vaccine constructs K Tokushige, T Wakita, C Pachuk, D Moradpour, DB Weiner, ... Hepatology 24 (1), 14-20, 1996 | 150 | 1996 |
| Hepatocellular carcinoma in non‐alcoholic steatohepatitis: growing evidence of an epidemic? E Hashimoto, K Tokushige Hepatology research 42 (1), 1-14, 2012 | 148 | 2012 |
| Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges E Hashimoto, K Tokushige, J Ludwig Hepatology research 45 (1), 20-28, 2015 | 146 | 2015 |
| Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the … K Tokushige, E Hashimoto, Y Horie, M Taniai, S Higuchi Journal of gastroenterology 46, 1230-1237, 2011 | 146 | 2011 |
| Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease H Kaneda, E Hashimoto, S Yatsuji, K Tokushige, K Shiratori Journal of gastroenterology and hepatology 21 (9), 1459-1465, 2006 | 144 | 2006 |
| Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization M Geissler, K Tokushige, CC Chante, VR Zurawski Jr, JR Wands Gastroenterology 112 (4), 1307-1320, 1997 | 139 | 1997 |
| Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH Y Yoshioka, E Hashimoto, S Yatsuji, H Kaneda, M Taniai, K Tokushige, ... Journal of gastroenterology 39, 1215-1218, 2004 | 133 | 2004 |
| Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers T Kawaguchi, T Shima, M Mizuno, Y Mitsumoto, A Umemura, Y Kanbara, ... PLoS One 13 (1), e0185490, 2018 | 122 | 2018 |
| Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? S Yatsuji, E Hashimoto, H Kaneda, M Taniai, K Tokushige, K Shiratori Journal of gastroenterology 40, 1130-1138, 2005 | 101 | 2005 |
| Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: an open‐label, pilot study H Hyogo, T Ikegami, K Tokushige, E Hashimoto, K Inui, Y Matsuzaki, ... Hepatology Research 41 (11), 1057-1065, 2011 | 99 | 2011 |
